Example: Heart Attack

Search clinical trials for: docetaxel

Total 2677 results

NCT05878028

Recruiting

L-TIL Plus Tislelizumab for PD1 Antibody Resistant aNSCLC

Non-small Cell Lung Cancer
NCT05875610

Recruiting

Preventive Approach Using Venlafaxine

Peripheral Neuropathy Due to Chemotherapy
NCT05871918

Recruiting

A Multicenter, Randomized, Open, Phase III Trial of ddEC-THPvs Evaluating the Efficacy and Safety of TCHP Neoadjuvant Therapy for HER2-positive Breast Cancer

HER-2 Positive Breast Cancer
NCT05863325

Not yet recruiting

A Study to Compare the Efficacy and Safety of HB1801 to Taxotere in Advanced Non-Small Cell Lung Cancer (NSCLC)

Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT05860868

Recruiting

Two Cycles VS Three Cycles Induction Chemotherapy in T1-4N2-3 Locally Advanced Nasopharyngeal Carcinoma

Locally Advanced Nasopharyngeal Carcinoma
NCT05858398

Not yet recruiting

Influence of Body Composition on Chemotherapy Outcomes in Localized Breast Cancer (FATTAX)

Breast Cancer
NCT05848011

Not yet recruiting

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer Recurrent Immunotherapy Androgen-Independent Prostatic Cancer Androgen-Resistant Prostatic Cancer Hormone Refractory Prostatic Cancer Immune Checkpoint Inhibitor Androgen-Independent Prostatic Neoplasms Androgen-Insensitive Prostatic Cance Inhibitory Checkpoint Molecule
NCT05843292

Not yet recruiting

Short-term Sintilimab in Combination With Taxane and Carboplatin for Neoadjuvant Therapy in Triple-negative Breast Cancer (NeoSTEP)

Triple-negative Breast Cancer
NCT05836584

Not yet recruiting

Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer

Gastric Adenocarcinoma Clinical Stage III Gastric Cancer AJCC v8 Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage I Gastric Cancer AJCC v8 Clinical Stage II Gastric Cancer AJCC v8 Clinical Stage IVA Gastric Cancer AJCC v8 Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8 Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 Localized Gastric Carcinoma Localized Gastroesophageal Junction Adenocarcinoma
NCT05838066

Not yet recruiting

Efficacy and Safety of KN026 in Combination With HB1801 in the First-line Treatment of Subjects With HER2-positive Recurrent or Metastatic Breast Cancer.

First-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
NCT05834413

Not yet recruiting

Clinical Study on the Prevention of Driver Gene Negative II-IIIa Lung Cancer Recurrence and Metastasis by Staged Chinese Herbal Medicine Combined With Chemotherapy and Immune Checkpoint Inhibitors

Lung Cancer
NCT05834348

Not yet recruiting

A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. (DELINOR)

Non-Small Cell Lung Cancer
NCT05826015

Not yet recruiting

AVB-500 (Batiraxcept) in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer

Recurrent High Grade Uterine Cancer
NCT05816499

Recruiting

Cadonilimab in Patients (Pts) With Advanced Non-small Cell Lung Cancer (NSCLC) (AK104IIT018)

NSCLC Stage IV NSCLC Stage IIIB NSCLC Stage IIIC
NCT05813015

Recruiting

Study of Comparing of With and Without Sequential Therapy of S-1

Chemotherapy Effect Locally Advanced Gastric Adenocarcinoma
NCT05802225

Recruiting

Clinical Study of the Efficacy and Safety of BCD-178 and Perjeta® as Neoadjuvant Therapy of HER2-Positive Breast Cancer (PREFER)

Breast Cancer
NCT05800587

Recruiting

Dose Attenuated Chemotherapy in Compromised Patients With Lung Cancer

Lung Cancer Non Small Cell Lung Cancer Small-cell Lung Cancer
NCT05800054

Recruiting

Effect of NST Whole-course Nutritional Management on Nutritional Status and Adverse Reactions in Esophageal Cancer

Esophageal Neoplasms Adverse Drug Event
NCT05798793

Not yet recruiting

Neoadjuvant Anti-PD-1 Immunotherapy With Chemotherapy in Resectable Locally Advanced Oral Squamous Cell Carcinoma (NEOPCOSCC)

Oral Squamous Cell Carcinoma
NCT05777278

Not yet recruiting

Savolitinib Plus Docetaxel as 2L in EGFR/ALK/ROS1/MET ex14m-wildtype NSCLC With MET Overexpression

Non-small Cell Lung Cancer
NCT05769725

Recruiting

A Study to Evaluate Serplulimab in Combination With Docetaxel +S-1 VS. Docetaxel +S-1 as Adjuvant Treatment Therapy in Stage IIIc Gastric Cancer

Serplulimab,Gastric Cancer, Adjuvant Therapy
NCT05762536

Not yet recruiting

Docetaxel or Cabazitaxel With or Without Darolutamide in mCRPC (DAROTAXEL)

Metastatic Castration-resistant Prostate Cancer
NCT05754853

Recruiting

A Study of MRG002 Versus Investigator's Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer

Advanced or Metastatic Urothelium Cancer
NCT05755646

Recruiting

Ice Plant Intensive Cream for the Prevention of Hand-Foot Syndrome in Breast Cancer: Pilot Randomized Controlled Trial (WIn-HFS)

Breast Cancer Hand-Foot Syndrome
NCT05753306

Recruiting

Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma Metastatic Malignant Neoplasm in the Peritoneum
NCT05733689

Not yet recruiting

Response Adapted Neoadjuvant Therapy in Gastroesophageal Cancers (RANT-GC Trial)

Gastroesophageal Adenocarcinoma
NCT05733351

Not yet recruiting

Vudalimab in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer

Stage IVB Prostate Cancer AJCC v8 Metastatic Prostate Adenocarcinoma Castration-Sensitive Prostate Carcinoma
NCT05727410

Recruiting

Neoadjuvant Nivolumab, Docetaxel, Cisplatin Therapy Followed by Surgery and Radiation Therapy for Resectable High Grade Salivary Gland Carcinoma

High-grade Salivary Gland Carcinoma
NCT05726370

Not yet recruiting

Preoperative Pembrolizumab and Chemotherapy in Resectable, Recurrent HNSCC

Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Recurrent Head and Neck Squamous Cell Carcinoma Resectable Head and Neck Squamous Cell Carcinoma
NCT05720026

Recruiting

Study to Evaluate the Efficacy and Safety of SYSA1901 vs. Perjeta® of HER2-Positive Breast Cancer

HER2-positive Breast Cancer
NCT05715931

Recruiting

Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma

HER2-positive Gastric Cancer Adenocarcinoma of the Stomach Adenocarcinoma of Esophagogastric Junction
NCT05713578

Recruiting

Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study

Cohort Studies
NCT05713838

Not yet recruiting

Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery

Esophagus Adenocarcinoma
NCT05714553

Not yet recruiting

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

Melanoma Renal Cell Carcinoma Gastric Cancer Non Small Cell Lung Cancer Metastatic Cancer Triple Negative Breast Cancer Advanced Solid Tumor Advanced Cancer Head and Neck Squamous Cell Carcinoma Endometrial Carcinoma
NCT05712356

Recruiting

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors (BOLSTER)

Head and Neck Cancer Esophageal Cancer Cholangiocarcinoma Intrahepatic Cholangiocarcinoma Head and Neck Squamous Cell Carcinoma Esophageal Squamous Cell Carcinoma Gallbladder Carcinoma Gallbladder Cancer Extrahepatic Cholangiocarcinoma Advanced Head and Neck Squamous Cell Carcinoma

Search clinical trials for: docetaxel

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lebanon

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations